Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure

[1]  H. Okano,et al.  Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. , 2010, The Journal of clinical investigation.

[2]  S. Ogawa,et al.  Abstract 3089: Heart Failure Causes Cholinergic Transdifferentiation of Cardiac Sympathetic Nerves via Gp130-mediated Cytokines , 2009 .

[3]  U. Schotten,et al.  Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. , 2009, Journal of molecular and cellular cardiology.

[4]  T. Yokoi,et al.  Exercise Training Alters Left Ventricular Geometry and Attenuates Heart Failure in Dahl Salt-Sensitive Hypertensive Rats , 2009, Hypertension.

[5]  A. McCulloch,et al.  An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. , 2008, The Journal of clinical investigation.

[6]  K. Yoshimi,et al.  Cardiac Sympathetic Rejuvenation: A Link Between Nerve Function and Cardiac Hypertrophy , 2007, Circulation research.

[7]  D. Hoover,et al.  Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene , 2006, Cell and Tissue Research.

[8]  S. Gerber,et al.  Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts , 2006, Hypertension.

[9]  Kazuto Kobayashi,et al.  Fate of transient catecholaminergic cell types revealed by site‐specific recombination in transgenic mice , 2004, Journal of neuroscience research.

[10]  H. Okano,et al.  Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. , 2004, The Journal of clinical investigation.

[11]  R. Vulapalli,et al.  Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. , 2002, American journal of physiology. Heart and circulatory physiology.

[12]  D. Mann,et al.  Functional Significance of Hemodynamic Overload–Induced Expression of Leukemia-Inhibitory Factor in the Adult Mammalian Heart , 2001, Circulation.

[13]  S. Makino,et al.  Interleukin-6 Family of Cytokines Mediate Angiotensin II-induced Cardiac Hypertrophy in Rodent Cardiomyocytes* , 2000, The Journal of Biological Chemistry.

[14]  T A Denton,et al.  Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. , 2000, Circulation.

[15]  M. Esler,et al.  Reduced myocardial nerve growth factor expression in human and experimental heart failure. , 2000, Circulation research.

[16]  J. Miyazaki,et al.  A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre‐mediated recombination , 2000, FEBS letters.

[17]  P. Poole‐Wilson,et al.  Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. , 1996, Circulation.

[18]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[19]  A. Quyyumi,et al.  Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.

[20]  K. Okada,et al.  Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension. , 1995, Circulation.

[21]  M. Böhm,et al.  Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.

[22]  W. Snider,et al.  Functions of the neurotrophins during nervous system development: What the knockouts are teaching us , 1994, Cell.

[23]  M. Kashiki,et al.  Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. , 1993, Circulation.

[24]  I. Meredith,et al.  Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake , 1993, Circulation.

[25]  P. Chang,et al.  Does Regional Norepinephrine Spillover Represent Local Sympathetic Activity? , 1991, Hypertension.

[26]  K. Baker,et al.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.

[27]  M. Akers,et al.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.

[28]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[29]  H. Thoenen,et al.  Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. , 1984, The EMBO journal.

[30]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[31]  P. Hjemdahl.  Catecholamine measurements by high-performance liquid chromatography. , 1984, The American journal of physiology.

[32]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[33]  E. Braunwald,et al.  Reduction of Cardiac Tyrosine Hydroxylase Activity in Experimental Congestive Heart Failure: Its Role In The Depletion Of Cardiac Norepinephrine Stores , 1967, Circulation research.